Initial characterization of a transgenic mouse with overexpression of the human D
Force of contraction
Human D1-dopamine receptor
Transgenic mouse heart
Journal
Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264
Informations de publication
Date de publication:
04 Jan 2024
04 Jan 2024
Historique:
received:
17
09
2023
accepted:
10
12
2023
medline:
5
1
2024
pubmed:
5
1
2024
entrez:
4
1
2024
Statut:
aheadofprint
Résumé
Dopamine can exert effects in the mammalian heart via five different dopamine receptors. There is controversy whether dopamine receptors increase contractility in the human heart. Therefore, we have generated mice that overexpress the human D
Identifiants
pubmed: 38177456
doi: 10.1007/s00210-023-02901-y
pii: 10.1007/s00210-023-02901-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 519414516
Informations de copyright
© 2024. The Author(s).
Références
Amenta F, Gallo P, Rossodivita A, Ricci A (1993) Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart. Naunyn Schmiedebergs Arch Pharmacol. 347(2):147–54. https://doi.org/10.1007/BF00169260
doi: 10.1007/BF00169260
pubmed: 8386324
Boknik P, Drzewiecki K, Eskandar J, Gergs U, Grote-Wessels S, Fabritz L, Kirchhof P, Müller FU, Stümpel F, Schmitz W, Zimmermann N, Kirchhefer U, Neumann J (2018) Phenotyping of mice with heart specific overexpression of A2A-adenosine receptors: evidence for cardioprotective effects of A2A-adenosine receptors. Front Pharmacol. 9:13. https://doi.org/10.3389/fphar.2018.00013
doi: 10.3389/fphar.2018.00013
pubmed: 29403384
pmcid: 5786519
Bravo G, Ghysel-Burton J, Jaumin P, Godfraind T (1991) A comparison of the inotropic effects of dopamine and epinine in human isolated cardiac preparations. J Pharmacol Exp Ther. 257(1):439–43
pubmed: 1850476
Brown L, Lorenz B, Erdmann E (1985) The inotropic effects of dopamine and its precursor levodopa on isolated human ventricular myocardium. Klin Wochenschr. 63(21):1117–23. https://doi.org/10.1007/BF02291093
doi: 10.1007/BF02291093
pubmed: 4079278
Cavallotti C, Mancone M, Bruzzone P, Sabbatini M, Mignini F (2010) Dopamine receptor subtypes in the native human heart. Heart Vessels. 25(5):432–7. https://doi.org/10.1007/s00380-009-1224-4
doi: 10.1007/s00380-009-1224-4
pubmed: 20676967
Czibik G, Mezdari Z, Murat Altintas D, Bréhat J, Pini M, d’Humières T, Delmont T, Radu C, Breau M, Liang H, Martel C, Abatan A, Sarwar R, Marion O, Naushad S, Zhang Y, Halfaoui M, Suffee N, Morin D, Adnot S, Hatem S, Yavari A, Sawaki D, Derumeaux G (2021) Dysregulated phenylalanine catabolism plays a key role in the trajectory of cardiac aging. Circulation. 144(7):559–574. https://doi.org/10.1161/CIRCULATIONAHA.121.054204
doi: 10.1161/CIRCULATIONAHA.121.054204
pubmed: 34162223
Deighton NM, Motomura S, Bals S, Zerkowski HR, Brodde OE (1992) Characterization of the beta adrenoceptor subtype(s) medi-ating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium. J Pharmacol Exp Ther. 262(2):532–8
pubmed: 1354251
Dörner MF, Boknik P, Köpp F, Buchwalow IB, Neumann J, Gergs U (2021) Mechanisms of systolic cardiac dysfunction in PP2A, PP5 and PP2AxPP5 double transgenic mice. Int J Mol Sci. 22(17):9448. https://doi.org/10.3390/ijms22179448
doi: 10.3390/ijms22179448
pubmed: 34502355
pmcid: 8431312
Gergs U, Boknik P, Buchwalow I, Fabritz L, Matus M, Justus I, Hanske G, Schmitz W, Neumann J (2004) Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J Biol Chem. 279(39):40827–34. https://doi.org/10.1074/jbc.M405770200
doi: 10.1074/jbc.M405770200
pubmed: 15247211
Gergs U, Neumann J, Simm A, Silber RE, Remmers FO, Läer S (2009) Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium. Naunyn Schmiedebergs Arch Pharmacol. 379(4):349–59. https://doi.org/10.1007/s00210-008-0371-y
doi: 10.1007/s00210-008-0371-y
pubmed: 19002436
Gergs U, Baumann M, Böckler A, Buchwalow IB, Ebelt H, Fabritz L, Hauptmann S, Keller N, Kirchhof P, Klöckner U, Pönicke K, Rueckschloss U, Schmitz W, Werner F, Neumann J (2010) Cardiac overexpression of the human 5-HT4 receptor in mice. Am J Physiol Heart Circ Physiol. 299(3):H788-98. https://doi.org/10.1152/ajpheart.00691.2009
doi: 10.1152/ajpheart.00691.2009
pubmed: 20639221
Gergs U, Böckler A, Ebelt H, Hauptmann S, Keller N, Otto V, Pönicke K, Schmitz W, Neumann J (2013) Human 5-HT4 receptor stimulation in atria of transgenic mice. Naunyn Schmiedebergs Arch Pharmacol. 386(5):357–67. https://doi.org/10.1007/s00210-013-0831-x
doi: 10.1007/s00210-013-0831-x
pubmed: 23307014
Gergs U, Trapp T, Bushnaq H, Simm A, Silber RE, Neumann J (2019) Age-dependent protein expression of serine/threonine phosphatases and their inhibitors in the human cardiac atrium. Adv Med. 2019:2675972. https://doi.org/10.1155/2019/2675972
doi: 10.1155/2019/2675972
pubmed: 30719459
pmcid: 6334353
Gergs U, Bernhardt G, Buchwalow IB, Edler H, Fröba J, Keller M, Kirchhefer U, Köhler F, Mißlinger N, Wache H, Neumann J (2019) Initial characterization of transgenic mice overexpressing human histamine H2 receptors. J Pharmacol Exp Ther. 369(1):129–141. https://doi.org/10.1124/jpet.118.255711
doi: 10.1124/jpet.118.255711
pubmed: 30728249
Huang M, Yang Z, Li Y, Lan H, Cyganek L, Yuecel G, Lang S, Bieback K, El-Battrawy I, Zhou X, Borggrefe M, Akin I (2022) Dopamine D1/D5 receptor signaling is involved in arrhythmogenesis in the setting of takotsubo cardiomyopathy. Front Cardiovasc Med. 8:777463. https://doi.org/10.3389/fcvm.2021.777463
doi: 10.3389/fcvm.2021.777463
pubmed: 35187102
pmcid: 8855058
Kirchhefer U, Baba HA, Hanske G, Jones LR, Kirchhof P, Schmitz W, Neumann J (2004) Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin. Am J Physiol Heart Circ Physiol. 287(5):H2216-25. https://doi.org/10.1152/ajpheart.00137.2004
doi: 10.1152/ajpheart.00137.2004
pubmed: 15205169
National Research Council (2011) Guide for the Care and Use of Laboratory Animals: Eighth Edition. The National Academies Press; Washington, DC
Neumann J, Boknik P, DePaoli-Roach AA, Field LJ, Rockman HA, Kobayashi YM, Kelley JS, Jones LR (1998) Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility. J Mol Cell Cardiol. 30(10):1991–2002. https://doi.org/10.1006/jmcc.1998.0760
doi: 10.1006/jmcc.1998.0760
pubmed: 9799653
Neumann J, Boknik P, Begrow F, Hanske G, Justus I, Mát'us M, Reinke U, Matherne GP, Schmitz W (2003a) Altered signal transduction in cardiac ventricle overexpressing A(1)-adenosine receptors. Cardiovasc Res. 60(3):529–37. https://doi.org/10.1016/j.cardiores.2003.09.012
doi: 10.1016/j.cardiores.2003.09.012
pubmed: 14659798
Neumann J, Hofmann B, Dhein S, Gergs U (2023b) Role of dopamine in the heart in health and disease. Int J Mol Sci. 24(5):5042. https://doi.org/10.3390/ijms24055042
doi: 10.3390/ijms24055042
pubmed: 36902474
pmcid: 10003060
Ozono R, O'Connell DP, Wang ZQ, Moore AF, Sanada H, Felder RA, Carey RM (1997) Localization of the dopamine D1 receptor protein in the human heart and kidney. Hypertension. 30(3 Pt 2):725–9. https://doi.org/10.1161/01.hyp.30.3.725
Ozono R, O'Connell DP, Vaughan C, Botkin SJ, Walk SF, Felder RA, Carey RM (1996) Expression of the subtype 1A dopamine receptor in the rat heart. Hypertension. 27(3 Pt 2):693–703. https://doi.org/10.1161/01.hyp.27.3.693
doi: 10.1161/01.hyp.27.3.693
pubmed: 8613227
Port JD, Gilbert EM, Larrabee P, Mealey P, Volkman K, Ginsburg R, Hershberger RE, Murray J, Bristow MR (1990) Neurotrans-mitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation. 81(3):929–38. https://doi.org/10.1161/01.cir.81.3.929
doi: 10.1161/01.cir.81.3.929
pubmed: 1968367
Rayo Abella LM, Gergs U, Pockes S, Hofmann B, Neumann J (2023) Effect of dopamine-1 receptor agonists in D1-dopamine receptor overexpressing mouse atrial preparations. Naunyn-Schmiedeberg's Arch Pharmacol 396(Suppl1):S43–S44
Regitz V, Bossaller C, Strasser R, Schüler S, Hetzer R, Fleck E (1990) Myocardial catecholamine content after heart transplantation. Circulation. 82(2):620–3. https://doi.org/10.1161/01.cir.82.2.620
doi: 10.1161/01.cir.82.2.620
pubmed: 2372908
Rump LC, Riera-Knorrenschild G, Schwertfeger E, Bohmann C, Spillner G, Schollmeyer P (1995) Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium. J Cardiovasc Pharmacol. 26(3):462–70. https://doi.org/10.1097/00005344-199509000-00017
doi: 10.1097/00005344-199509000-00017
pubmed: 8583789
Tonnarini G et al (2011) Dopamine receptor subtypes in the human coronary vessels of healthy subjects. J Recept Signal Transduct Res. 31(1):33–8. https://doi.org/10.3109/10799893.2010.506878
doi: 10.3109/10799893.2010.506878
pubmed: 20704467
Wagner J, Schümann HJ, Knorr A, Rohm N, Reidemeister JC (1980) Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adrenoceptors mediating positive inotropic effects in human atrial preparations. Naunyn Schmiedebergs Arch Pharmacol. 312(1):99–102. https://doi.org/10.1007/BF00502581
doi: 10.1007/BF00502581
pubmed: 6248799
Yamaguchi T, Sumida TS, Nomura S, Satoh M, Higo T, Ito M, Ko T, Fujita K, Sweet ME, Sanbe A, Yoshimi K, Manabe I, Sasaoka T, Taylor MRG, Toko H, Takimoto E, Naito AT, Komuro I (2020) Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure. Nat Commun. 11(1):4364. https://doi.org/10.1038/s41467-020-18128-x
doi: 10.1038/s41467-020-18128-x
pubmed: 32868781
pmcid: 7459304
Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli O (1990) Cloning and expression of human and rat D1 dopamine receptors. Nature. 347(6288):76–80. https://doi.org/10.1038/347076a0
doi: 10.1038/347076a0
pubmed: 2168520